{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:45:55Z","timestamp":1793310355764,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["RG\/17\/12\/33167"],"award-info":[{"award-number":["RG\/17\/12\/33167"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["RG\/17\/12\/33167"],"award-info":[{"award-number":["RG\/17\/12\/33167"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["RE\/18\/5\/34216"],"award-info":[{"award-number":["RE\/18\/5\/34216"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00014\/4"],"award-info":[{"award-number":["MC_UU_00014\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T016701\/1"],"award-info":[{"award-number":["MR\/T016701\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00014\/4"],"award-info":[{"award-number":["MC_UU_00014\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T016701\/1"],"award-info":[{"award-number":["MR\/T016701\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","award":["GN2788"],"award-info":[{"award-number":["GN2788"]}],"id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s13300-021-01058-2","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T02:14:37Z","timestamp":1622600077000},"page":"1901-1914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9569-6132","authenticated-orcid":false,"given":"Jane L.","family":"Tarry-Adkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imogen D.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Ozanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"1058_CR1","unstructured":"Agency for Healthcare Research and Quality Rockville MD. Medical Expenditure Panel Survey (MEPS). 2018. https:\/\/www.ahqr.gov\/data\/meps.html. Accessed 3 Mar 2021."},{"key":"1058_CR2","first-page":"119","volume":"21","author":"World Health Organisation","year":"2019","unstructured":"World Health Organisation. World Health Organisation model list of essential medicines. Ment Holist Heal Some Int Perspect. 2019;21:119\u201334.","journal-title":"Ment Holist Heal Some Int Perspect"},{"key":"1058_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF00253736","volume":"23","author":"RA DeFronzo","year":"1982","unstructured":"DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982;23:313\u20139.","journal-title":"Diabetologia"},{"key":"1058_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1056\/NEJM199803263381303","volume":"338","author":"SE Inzucchi","year":"1998","unstructured":"Inzucchi SE, Maggs DG, Spollett GR, et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 1998;338:867\u201373.","journal-title":"N Engl J Med"},{"issue":"223","key":"1058_CR5","first-page":"8","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem. 2000;275(223):8.","journal-title":"J Biol Chem"},{"key":"1058_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Meyers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167\u201374.","journal-title":"J Clin Invest"},{"key":"1058_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510:542\u20136.","journal-title":"Nature"},{"key":"1058_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/2042018810380215","volume":"3","author":"H Lashen","year":"2010","unstructured":"Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2010;3:117\u201328.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1058_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","volume":"217","author":"R Romero","year":"2017","unstructured":"Romero R, Erez O, H\u00fcttemann M, et al. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol. 2017;217:282\u2013302.","journal-title":"Am J Obstet Gynecol"},{"key":"1058_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1370\/afm.343","volume":"3","author":"KM Levri","year":"2005","unstructured":"Levri KM, Slaymaker E, Last A, et al. Metformin as treatment for overweight and obese adults: a systematic review. Ann Fam Med. 2005;3:457\u201361.","journal-title":"Ann Fam Med"},{"key":"1058_CR11","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2147\/CMAR.S200059","volume":"11","author":"P Saraei","year":"2019","unstructured":"Saraei P, Asadi I, Kakar MA, Moradi-Kor N. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer Manag Res. 2019;11:3295\u2013313.","journal-title":"Cancer Manag Res"},{"key":"1058_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.36849\/JDD.2020.4874","volume":"19","author":"CT Sung","year":"2020","unstructured":"Sung CT, Chao T, Lee A, et al. Oral metformin for treating dermatological diseases: a systematic review. J Drugs Dermatol. 2020;19:713\u201320.","journal-title":"J Drugs Dermatol"},{"key":"1058_CR13","doi-asserted-by":"publisher","unstructured":"Aye ILMH, Aiken CE, Charnock-Jones DS, Smith GCS. Placental energy metabolism in health and disease\u2014significance of development and implications for preeclampsia. Am J Obstet Gynecol. 2020. https:\/\/doi.org\/10.1016\/j.ajog.2020.11.005.","DOI":"10.1016\/j.ajog.2020.11.005"},{"key":"1058_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/ph13090234","volume":"13","author":"T Salvatore","year":"2020","unstructured":"Salvatore T, Pafundi PC, Galiero R, et al. Metformin: a potential therapeutic tool for rheumatologists. Pharmaceuticals. 2020;13:234.","journal-title":"Pharmaceuticals"},{"key":"1058_CR15","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2337\/db14-1388","volume":"64","author":"T Dujic","year":"2015","unstructured":"Dujic T, Zhou K, Donnelly LA, Tavendale R, Palmer CAN, Pearson ER. Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study. Diabetes. 2015;64:1786\u201393.","journal-title":"Diabetes"},{"key":"1058_CR16","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","volume":"51","author":"CJ Bailey","year":"2008","unstructured":"Bailey CJ, Wilcock C, Scarpello JHB. Metformin and the intestine. Diabetologia. 2008;51:1552\u20133.","journal-title":"Diabetologia"},{"key":"1058_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","volume":"59","author":"LJ McCreight","year":"2016","unstructured":"McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia. 2016;59:426\u201335.","journal-title":"Diabetologia"},{"key":"1058_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0168-8227(88)80022-6","volume":"4","author":"N Vidon","year":"1988","unstructured":"Vidon N, Chaussade S, Noel M, Franchisseur C, Huchet B, Bernier JJ. Metformin in the digestive tract. Diabetes Res Clin Pract. 1988;4:223\u20139.","journal-title":"Diabetes Res Clin Pract"},{"key":"1058_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc15-1531","volume":"39","author":"JB Buse","year":"2016","unstructured":"Buse JB, DeFronzo RA, Rosenstock J, et al. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care. 2016;39:198\u2013205.","journal-title":"Diabetes Care"},{"key":"1058_CR20","first-page":"1","volume":"13","author":"RR Henry","year":"2018","unstructured":"Henry RR, Frias JP, Walsh B, et al. Improved glycemic control with minimal systemic metformin exposure. Effects of metformin delayed-release (metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes. PLoS One. 2018;13:1\u201317.","journal-title":"PLoS One"},{"key":"1058_CR21","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"1058_CR22","unstructured":"Castellotti DS, Cambiaghi AS. Comparison between metformin HCl and metformin HCl extended release tablets in women with polycystic ovary syndrome (PCOS). Hum Reprod. 2007. (Poster P-469)."},{"key":"1058_CR23","first-page":"225","volume":"19","author":"M Hameed","year":"2017","unstructured":"Hameed M, Khan K, Salman S, Mehmood N. Dose comparison and side effect profile of metformin extended release versus metformin immediate release. J Ayub Med Coll Abbottabad. 2017;19:225\u20139.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"1058_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/dom.13104","volume":"20","author":"N Aggarwal","year":"2018","unstructured":"Aggarwal N, Singla A, Mathieu C, et al. Metformin extended-release versus immediate-release: an international, randomized, double-blind, head-to-head trial in pharmacotherapy-na\u00efve patients with type 2 diabetes. Diabetes Obes Metab. 2018;20:463\u20137.","journal-title":"Diabetes Obes Metab"},{"key":"1058_CR25","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2147\/DDDT.S131670","volume":"11","author":"G Derosa","year":"2017","unstructured":"Derosa G, D\u2019Angelo A, Romano D, Maffioli P. Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes. Drug Des Devel Ther. 2017;11:1481\u20138.","journal-title":"Drug Des Devel Ther"},{"key":"1058_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0149-2918(03)80093-0","volume":"25","author":"K Fujioka","year":"2003","unstructured":"Fujioka K, Pans M, Joyal S. Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation. Clin Ther. 2003;25:515\u201329.","journal-title":"Clin Ther"},{"key":"1058_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1742-1241.2008.01733.x","volume":"62","author":"H Gao","year":"2008","unstructured":"Gao H, Xiao W, Wang C, et al. The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study. Int J Clin Pract. 2008;62:695\u2013700.","journal-title":"Int J Clin Pract"},{"key":"1058_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.metabol.2007.03.018","volume":"56","author":"CH Hsieh","year":"2007","unstructured":"Hsieh CH, He CT, Lee CM, Wu LY, Hung YJ. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus. Metabolism. 2007;56:1087\u201392.","journal-title":"Metabolism"},{"key":"1058_CR29","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/dom.13190","volume":"20","author":"L Ji","year":"2018","unstructured":"Ji L, Liu J, Yang J, et al. Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-na\u00efve Chinese patients: analysis of results from the CONSENT trial. Diabetes Obes Metab. 2018;20:1006\u201313.","journal-title":"Diabetes Obes Metab"},{"key":"1058_CR30","unstructured":"Niecestro R, Isaacsohn J, Sterman A, Friedhoff L, Brett V, Cullen E. Comparison of lipid control with 2000 and 2500mg of metformin XT vs. immediate-release metformin in patients with type 2 diabetes. Diabetes. 2003."},{"key":"1058_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/diacare.29.04.06.dc05-1967","volume":"29","author":"S Schwartz","year":"2006","unstructured":"Schwartz S, Fonseca V, Berner B, Cramer M, Chiang YK, Lewin A. Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes. Diabetes Care. 2006;29:759\u201364.","journal-title":"Diabetes Care"},{"key":"1058_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5428\/pcar20120612","volume":"12","author":"L Xue","year":"2015","unstructured":"Xue L, Tang W. Pharmacoeconomic evaluation of the treatment for type 2 diabetes complicated with lung cancer by different dosage forms of metformin. Pharm Care Res. 2015;12:438\u201341.","journal-title":"Pharm Care Res"},{"key":"1058_CR33","first-page":"101","volume":"30","author":"JY Zheng","year":"2009","unstructured":"Zheng JY, Tang YH, Zou JJ. Extended-release metformin in treatment of patients with type 2 diabetes: efficacy and safety. Acad J Second Mil Med Univ. 2009;30:101\u20133.","journal-title":"Acad J Second Mil Med Univ"},{"key":"1058_CR34","unstructured":"Fineman M, Buse JB, DeFronzo RA, et al. The primary glucose-lowering effect of metformin resides in the gut not the circulation-results from 7-day and 12-week studies. Diabetes. 2015. (Poster 1207-P)."},{"key":"1058_CR35","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1517\/14656566.2012.705829","volume":"12","author":"S Ali","year":"2012","unstructured":"Ali S, Fonseca V. Overview of metformin: special focus on metformin extended release. Expert Opin Pharmacother. 2012;12:1797\u2013805.","journal-title":"Expert Opin Pharmacother"},{"key":"1058_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2165\/00019053-200321110-00005","volume":"21","author":"JW Ramsdell","year":"2003","unstructured":"Ramsdell JW, Braunstein SN, Stephens JM, Bell CF, Botteman MF, Devine ST. Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus. Pharmacoeconomics. 2003;21:819\u201337.","journal-title":"Pharmacoeconomics"},{"key":"1058_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll AP, Chen M, Taskar P, et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature. 2020;578:444\u20138.","journal-title":"Nature"},{"key":"1058_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000333963","volume":"96","author":"D Stevanovic","year":"2012","unstructured":"Stevanovic D, Janjetovic K, Misirkic M, et al. Intracerebroventricular administration of metformin inhibits ghrelin-induced hypothalamic AMP-kinase signalling and food intake. Neuroendocrinology. 2012;96:24\u201331.","journal-title":"Neuroendocrinology"},{"key":"1058_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","volume":"14","author":"A Yerevanian","year":"2019","unstructured":"Yerevanian A, Soukas AA. Metformin: mechanisms in human obesity and weight loss. Curr Obes Rep. 2019;14:156\u201364.","journal-title":"Curr Obes Rep"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01058-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-021-01058-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01058-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T04:22:35Z","timestamp":1625718155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-021-01058-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1058"],"URL":"https:\/\/doi.org\/10.1007\/s13300-021-01058-2","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}